This letter was written by Arild Knutsen, a Norwegian drug user activist, to raise awareness of how the Covid-19 epidemic can affect people who use drugs – and how to protect them.
On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.
The Commission on Narcotic Drugs (CND) is the largest international drug policy decision making forum in the world. This year, at the 63rd session of the CND, our video advocacy team produced four short video reports to inform the public about some of the major developments.
The EU Drugs Strategy (2013-20) expires this year and there are huge gaps in its implementation. Policy documents that are not enforced damage the credibility of the EU. To avoid this, we should revise the paradigm and create a new framework for actions.
It is time for drug professionals, including the harm reduction community, to have a say about the upcoming regulation of the European cannabis market. If not, we miss an important historical opportunity to shape the future.
The Correlation European Harm Reduction Network published its first monitoring report (download here!) of harm reduction in Europe. On this occasion, we interviewed Eberhard Schatz, one of the two coordinators of the network about new trends and challenges.
Many people know the story of the drunkard from Saint-Exupéry’s Little Prince, who drinks because he is ashamed, and is ashamed because he drinks. This article is about how ancient wisdom and modern science teach us to avoid shaming as a tool to change people.
What is your style in advocacy? Are you a rational owl, an activist elephant, a barking watchdog, or a sly old fox? This article will help you to navigate the zoo.
The overdose epidemic in Scotland attracted international media attention but we know less about what is the situation in other parts of the UK. We interviewed Martin Balekbrough, the CEO of the Kaleidoscope Project from Wales.
Chedrik Charvet of the Regenboog Groep explains in detail the mission and the successes of drug consumption rooms.